Nour-El-Houda Ould-Chikh
Overview
Explore the profile of Nour-El-Houda Ould-Chikh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Auclair N, Sane A, Ahmarani L, Ould-Chikh N, Patey N, Beaulieu J, et al.
J Lipid Res
. 2023 Aug;
64(9):100423.
PMID: 37558128
Biallelic pathogenic variants of the Sar1b gene cause chylomicron retention disease (CRD) whose central phenotype is the inability to secrete chylomicrons. Patients with CRD experience numerous clinical symptoms such as...
2.
Feldman F, Koudoufio M, El-Jalbout R, Sauve M, Ahmarani L, Sane A, et al.
Antioxidants (Basel)
. 2023 Jan;
12(1).
PMID: 36670951
While the prevalence of metabolic syndrome (MetS) is steadily increasing worldwide, no optimal pharmacotherapy is readily available to address its multifaceted risk factors and halt its complications. This growing challenge...
3.
Dube L, Spahis S, Lachaine K, Lemieux A, Monhem H, Poulin S, et al.
Antioxid Redox Signal
. 2022 Jan;
37(1-3):54-83.
PMID: 35072542
Metabolic syndrome (MetS) prevalence continues to grow and represents a serious public health issue worldwide. This multifactorial condition carries the risk of hastening the development of type 2 diabetes (T2D),...
4.
Sauve M, Feldman F, Koudoufio M, Ould-Chikh N, Ahmarani L, Sane A, et al.
Biomedicines
. 2021 Sep;
9(9).
PMID: 34572325
Background And Aims: The increasing prevalence and absence of effective global treatment for metabolic syndrome (MetS) are alarming given the potential progression to severe non-communicable disorders such as type 2...